spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, Z.
Right arrow Articles by Gonias, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, Z.
Right arrow Articles by Gonias, S. L.

Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells

Zhong Ma1, Donna J. Webb2, Minji Jo1 and Steven L. Gonias1,3,*

1 Departments of Pathology,
2 Cell Biology2, and
3 Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA



View larger version (11K):

[in a new window]
 
Fig. 1. Equilibrium binding of 125I-DIP-uPA to MDA-MB-231 cells. MDA-MB-231 cells were acid-washed and then incubated with increasing concentrations of 125I-DIP-uPA for 4 hours at 4°C. The specific binding isotherm is shown in panel A. Each point represents the mean ± s.e.m. of results from two separate experiments, each with triplicate determinations. The Scatchard transformation of the same data is shown in panel B. B/F, bound/free.

 


View larger version (18K):

[in a new window]
 
Fig. 2. Accumulation of uPA in MDA-MB-231 cell-conditioned medium. (A) Immunoblot analysis was used to detect uPA in serum-free medium conditioned by MDA-MB-231 cells in the presence or absence of uPA-specific antibody for 24 hours. A standard curve was generated using known amounts of purified uPA (5-50 ng). The low mobility band is assumed to represent uPA-PAI-1 complex, due to the apparent molecular mass. (B) Levels of UPA in CM were quantitated by densitometry, in comparison with the standard curve (n=3).

 


View larger version (35K):

[in a new window]
 
Fig. 3. ERK phosphorylation in MDA-MB-231 cells treated with uPA- or uPAR-specific antibody. Cells were treated for 24 hours with uPA-specific antibody (panel A), uPAR-specific antibody (panel B) or nonimmune IgG from mouse or rabbit (panel C). Lanes labeled ‘-’ were treated with vehicle. Cell extracts were subjected to SDS-PAGE and electrotransfered to nitrocellulose membranes, which were probed to detect phosphorylated ERK, stripped and then re-probed to detect total ERK. Duplicate determinations from separate cultures are shown in panels A and B.

 


View larger version (33K):

[in a new window]
 
Fig. 4. Activation of MCF-7 cell ERK by MDA-MB-231 cell CM. MDA-MB-231 cells were allowed to condition serum-free medium for 24 hours. The CM was subjected to centrifugation at 15,000 g for 10 minutes to remove debris and then added to cultures of MCF-7 cells that had been serum-starved for 12 hours. Some samples of CM were pre-incubated with uPA-specific antibody (25 µg/ml) or mouse nonimmune IgG (25 µg/ml) for 20 minutes at 37°C before being added to the MCF-7 cell cultures. ERK phosphorylation was assessed 1 minute after addition of the CM.

 


View larger version (21K):

[in a new window]
 
Fig. 5. uPA-specific antibody inhibits the growth of MDA-MB-231 cells. (A) The indicated number of MDA-MB-231 cells was plated in 96-well plates, in triplicate, and cultured overnight. The cultures were then transferred into serum-free medium and incubated for 24 hours with uPA-specific antibody (+) or vehicle (-). Cell growth was determined by MTT assay. The number of viable cells in each culture prior to the 24 hour culturing period was determined as a control (labeled ‘C’). The asterisk indicates that antibody significantly altered cell growth compared with vehicle (unpaired t-test, P<0.05, n=3). (B) 4x104 MDA-MB-231 cells were plated in 48-well plates, in triplicate, and cultured at 37°C for 24 hours. The cells were then incubated with increasing amount of uPA-specific antibody, PD098059 (10 µM) or mouse nonimmune IgG (25 µg/ml) for 30 hours. [3H]thymidine incorporation was measured. The asterisk indicates that the value is significantly different from the control (unpaired t-test, P<0.01, n=3).

 


View larger version (22K):

[in a new window]
 
Fig. 6. uPAR-specific antibody inhibits the growth of MDA-MB-231 cells. (A) 5x103 cells were plated in 96-well plates, in triplicate, and incubated for 24 hours. The cells were subjected to a mild acid wash and incubated with DMSO (0.1% v/v), PD098059 (10 µM), rabbit nonimmune IgG (50 µg/ml), uPAR-specific antibody (50 µg/ml) or PD098059 (10 µM) plus uPAR-specific antibody (50 µg/ml). Cell growth was measured by MTT assay. The asterisk indicates that the treatment is significantly different from control (unpaired t-test, P<0.015, n=3). The dagger indicates that this result is not significantly different than the result obtained with uPAR-specific antibody or PD098059 alone. (B) An identical series of incubations was executed and cell growth was measured by the [3H]thymidine incorporation method. Asterisks/daggers are as for part A.

 


View larger version (28K):

[in a new window]
 
Fig. 7. uPA-and uPAR-specific antibodies induce apoptosis in MDA-MB-231 cells. (A) MDA-MB-231 cells were cultured in 96-well plates and then incubated in serum-free medium, supplemented with uPA-specific antibody or PD098059 (10 µM) for 24 hours. Cytoplasmic nucleosomes were detected by ELISA. (B) MDA-MB-231 cells were cultured in 6-well plates and treated with DMSO (0.1% v/v), PD098059 (10 µM), mouse nonimmune IgG (25 µg/ml), uPA-specific antibody (25 µg/ml) or uPA-specific antibody (25 µg/ml) plus PD098059 (10 µM) for 24 hours. Caspase-3 activity was then measured. (C) MDA-MB-231 cells were subjected to mild acid wash and then cultured in serum-free medium containing DMSO (0.1% v/v), PD098059 (10 µM), uPAR-specific antibody (50 µg/ml) or uPAR-specific antibody (50 µg/ml) plus PD098059 (10 µM) for 24 hours. Cytoplasmic nucleosomes were detected by ELISA. (D) MDA-MB-231 cells were subjected to a mild acid wash and then cultured for 24 hours in serum-free medium containing DMSO (0.1% v/v), PD098059 (10 µM), rabbit nonimmune IgG (50 µg/ml), uPAR-specific antibody (50 µg/ml) or uPAR-specific antibody (50 µg/ml) plus PD098059 (10 µM). Caspase-3 activity was determined. The asterisk indicates a significant difference compared with control (unpaired t-test, P<0.05, n=3). The dagger indicates that uPA- or uPAR-specific antibody in combination with PD098059 did not significantly alter apoptosis compared with either reagent alone.

 


View larger version (27K):

[in a new window]
 
Fig. 8. uPA antisense oligodeoxynucleotides inhibit MDA-MB-231 cell growth and promote apoptosis. (A) MDA-MB-231 cells were treated with uPA antisense, sense or nonsense oligodeoxynucleotides for 24 hours, cultured in serum-containing medium for 24 hours and then in serum-free medium for 24 hours. uPA accumulation in serum-free conditioned medium was assessed by immunoblot analysis. (B) uPA levels in CM were quantitated by densitometry and standardized to the level observed in control cultures. (C) MDA-MB-231 cells were treated with oligodeoxynucleotides according to the protocol used to measure uPA levels. Cell growth was determined by MTT assay. The asterisk indicates a significant difference compared with the control (unpaired t-test, P<0.05, n=3). (D) MDA-MB-231 cells were treated with oligodeoxynucleotides. Cytoplasmic nucleosomes were detected by ELISA. The asterisk indicates a significant difference compared with the control (unpaired t-test, P<0.05, n=3). Values in B-D represent mean±s.e.m.

 


View larger version (41K):

[in a new window]
 
Fig. 9. Expression of uPA and uPAR is regulated by ERK in MDA-MB-231 cells. MDA-MB-231 cells were treated with PD098059 (10 µM or 50 µM) or with vehicle for 24 hours in serum-free medium. (A) Levels of uPA, cell-associated uPAR and soluble uPAR in CM were determined by immunoblot analysis (representative of three separate experiments). (B) PGAD, uPA and uPAR mRNA levels were analyzed in total RNA isolates.

 





© The Company of Biologists Ltd 2001